NCLAT: Unenforced Equitable Mortgage is Corporate Debtor’s Asset, Not to Be Treated as Margin Money  ||  NCLT Approves Hindustan Unilever’s Ice Cream Business Demerger into Kwality Wall’s  ||  Supreme Court: Bar Councils Cannot Charge Over Rs 750 for Enrollment or Withhold Applicants’ Docs  ||  SC Cancels POCSO Conviction, Observing Crime Resulted from Love, Not Lust, After Marriage  ||  Supreme Court: Advocates Can be Summoned Only under S.132 BSA Exceptions with Prior Officer Approval  ||  Allahabad HC: Juvenile Conviction Cannot be Treated as Disqualification for Government Jobs  ||  Delhi HC: DV Act Rights of Daughter-in-Law Cannot Deny In-Laws’ Right to Reside in Home  ||  Delhi HC: Waitlist Panel Cannot Be Segregated, Vacancies Must Be Filled From Valid Waitlist  ||  Delhi HC: Matrimonial FIR Cannot Be Quashed If Couple’s Settlement Agreement is Not Executed  ||  Delhi HC Bars All India Carrom Federation from Using “India” or “Indian” in its Name    

Cabinet approves MoU between India and Uzbekistan on cooperation for establishment of Uzbek-Indian Free Pharmaceutical Zone in the Andijan region of Uzbekistan- (Press Information Bureau) (26 Sep 2018)

MANU/PIBU/1352/2018

Law of Medicine

The Union Cabinet chaired by Prime Minister Shri Narendra Modi has approved the Memorandum of Understanding (MoU) between India and Uzbekistan for establishment of the Uzbek-Indian Free Pharmaceutical Zone in the Andijan Region of Uzbekistan. The MoU will be signed during the visit of President of Uzbekistan to India on 1st October 2018.

In view of the importance of the growth of the pharmaceuticals and biopharmaceutical industry in both countries and the importance of mutual cooperation in trade, industry and production in the pharmaceutical and biopharmaceutical sectors, both the countries have been trying to establish a formal mechanism of bilateral cooperation. The MoU will create an enabling framework of cooperation for setting up an Uzbek-Indian Free Pharmaceuticals Zone in Andijan region of Uzbekistan. It will also facilitate Indian pharmaceutical and biopharmaceutical companies to invest in and establish production facilities in the Uzbek-Indian Free Pharma Zone of Andijan for manufacture of Pharmaceutical Products.

Tags : MOU   APPROVAL   PHARMACEUTICAL ZONE  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved